Stay updated with breaking news from Nasdaq Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a research note published on Wednesday morning. The firm issued a buy rating on the stock. Separately, Truist Financial boosted their target price on Amneal Pharmaceuticals from $6.00 to $7.00 and gave the stock a buy rating in a research note on […]
StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a report published on Wednesday. The firm issued a buy rating on the stock. Separately, Truist Financial upped their target price on Amneal Pharmaceuticals from $6.00 to $7.00 and gave the company a buy rating in a research report on Wednesday, November […]
StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a buy rating on the stock. Separately, Truist Financial upped their price objective on shares of Amneal Pharmaceuticals from $6.00 to $7.00 and gave the company a buy rating in […]
Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price […]
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 2,650,000 shares, a decrease of 16.7% from the November 30th total of 3,180,000 shares. Approximately 2.4% of the shares of the company are short sold. Based […]